Mauna Kea touts Cellvizio pancreatic cyst diagnosis study data

This study demonstrates the potential benefit of using Cellvizio as a standard of care for this major application,” CEO Sacha Loiseau said in a prepared statement.
Last month, Cook Medical said its urology business launched the Cellvizio system with a deal to distribute the device globally.
The post Mauna Kea touts Cellvizio pancreatic cyst diagnosis study data appeared first on MassDevice.

Source: Mass Device - October 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Imaging Oncology Mauna Kea Technologies Source Type: news